Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalency of CM082 in Healthy Chinese Volunteers
NCT04328506Phase 1Completed
- Sponsor
- AnewPharma Company, Ltd.
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vorolanib in malignant solid tumor (4 arms), sponsored by AnewPharma Company, Ltd. Primary endpoints: Peak plasma concentration, Area under the plasma concentration versus time curve and 1 more. Started Jun 2020; status: completed.
02
Drugs
vorolanib
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT04328506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328506.